PTC Therapeutics, Inc. (PTCT): Depreciation & Amortization
$38.81M
Year ended 2025-12-31
$55.30M
Trailing 12 months to 2026-06-30
-33.0%
3-year compound annual growth
-2.2%
5-year compound annual growth
+29.7%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $38.81M | -48.7% | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | $75.66M | -68.0% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | $236.59M | +83.6% | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | $128.84M | +100.9% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $64.13M | +47.5% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $43.49M | +35.1% | 2023-02-21, From 2020-01-01 |
| 2019-12-31 | $32.18M | +23.4% | 2022-02-22, From 2019-01-01 |
| 2018-12-31 | $26.09M | +47.5% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $17.68M | +437.4% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $3.29M | +14.4% | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | $2.88M | n/a | 2018-03-06, From 2015-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $38.81M | -48.7% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $51.51M | +13.0% |
| Alkermes plc. (ALKS) | 2025-12-31 | $27.16M | -4.8% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $44.52M | +18.0% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $10.00M | -37.5% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $31.27M | +3.6% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $1.51M | +37.4% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $85.60M | +18.1% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $79.56M | -17.5% |
Compare PTCT, PAHC, ALKS, SRPT side by side · Screen every company in Pharmaceutical Preparations ↗